Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| E Qure Corporation (CE) | EQUR | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0002 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0002 | 0.0002 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0002 - 0.0399 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.0002 | USD |
E Qure Corporation (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 9.36k | 46.79M | 24.13M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
E Qure (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EQUR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.0003 | 0.0399 | 0.0002 | 0.0087657 | 3,978 | -0.0001 | -33.33% |
| 3 Years | 0.041 | 0.065 | 0.0002 | 0.0317851 | 20,029 | -0.0408 | -99.51% |
| 5 Years | 0.12 | 0.16 | 0.0001 | 0.0445184 | 15,804 | -0.1198 | -99.83% |
E Qure (CE) Description
| E-Qure Corp. is engaged in the development and commercialization of its patented Bio-electrical Signal Therapy or BST Device, a new electrotherapy for the noninvasive treatment of hard to heal chronic wounds using electrical simulation to promote renewed blood flow and oxygen in order to induce local cell regeneration. The BST Device, designed to address limitations of competitors' wound care devices, is used to treat chronic wounds, primarily Stage III and Stage IV ulcers, and severe Stage II wounds. Our BST Device has received: (i) regulatory approval and CE certification permitting sale in the European Union markets; (ii) official certification from the Israeli Ministry of Health for use of the BST Device in Israel. The Company has entered into distribution agreements with third parties to market and sell its BST Device in several countries and is in the process of developing world-wide distribution arrangements. Company will launch a double arm, randomized clinical trial (RCT - Randomized Control Trial) in Israel to help promote the use of the BST device with local health care providers. |
